Beneficial Effects of Prebiotic Saccharomyces cerevisiae Mannan on Allergic Asthma Mouse Models

One of the unmet needs for asthma management is a new therapeutic agent with both anti-inflammatory and anti-smooth muscle (ASM) remodeling effects. The mannose receptor (MR) family plays an important role in allergen uptake and processing of major allergens Der p 1 and Fel d 1. We have previously r...

Full description

Saved in:
Bibliographic Details
Main Authors: D. Betty Lew, Christie F. Michael, Tracie Overbeck, W. Scout Robinson, Erin L. Rohman, Jeffrey M. Lehman, Jennifer K. Patel, Brandi Eiseman, Kim S. LeMessurier, Amali E. Samarasinghe, M. Waleed Gaber
Format: Article
Language:English
Published: Wiley 2017-01-01
Series:Journal of Immunology Research
Online Access:http://dx.doi.org/10.1155/2017/3432701
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832565349808078848
author D. Betty Lew
Christie F. Michael
Tracie Overbeck
W. Scout Robinson
Erin L. Rohman
Jeffrey M. Lehman
Jennifer K. Patel
Brandi Eiseman
Kim S. LeMessurier
Amali E. Samarasinghe
M. Waleed Gaber
author_facet D. Betty Lew
Christie F. Michael
Tracie Overbeck
W. Scout Robinson
Erin L. Rohman
Jeffrey M. Lehman
Jennifer K. Patel
Brandi Eiseman
Kim S. LeMessurier
Amali E. Samarasinghe
M. Waleed Gaber
author_sort D. Betty Lew
collection DOAJ
description One of the unmet needs for asthma management is a new therapeutic agent with both anti-inflammatory and anti-smooth muscle (ASM) remodeling effects. The mannose receptor (MR) family plays an important role in allergen uptake and processing of major allergens Der p 1 and Fel d 1. We have previously reported that ASM cells express a mannose receptor (ASM-MR) and that mannan derived from Saccharomyces cerevisiae (SC-MN) inhibits mannosyl-rich lysosomal hydrolase-induced bovine ASM cell proliferation. Using a humanized transgenic mouse strain (huASM-MRC2) expressing the human MRC2 receptor in a SM tissue-specific manner, we have demonstrated that ASM hyperplasia/hypertrophy can occur as early as 15 days after allergen challenge in this mouse model and this phenomenon is preventable with SC-MN treatment. This proof-of-concept study would facilitate future development of a potential asthma therapeutic agent with dual function of anti-inflammatory and anti-smooth muscle remodeling effects.
format Article
id doaj-art-051df313f10c41328f2b06ffb029af45
institution Kabale University
issn 2314-8861
2314-7156
language English
publishDate 2017-01-01
publisher Wiley
record_format Article
series Journal of Immunology Research
spelling doaj-art-051df313f10c41328f2b06ffb029af452025-02-03T01:07:53ZengWileyJournal of Immunology Research2314-88612314-71562017-01-01201710.1155/2017/34327013432701Beneficial Effects of Prebiotic Saccharomyces cerevisiae Mannan on Allergic Asthma Mouse ModelsD. Betty Lew0Christie F. Michael1Tracie Overbeck2W. Scout Robinson3Erin L. Rohman4Jeffrey M. Lehman5Jennifer K. Patel6Brandi Eiseman7Kim S. LeMessurier8Amali E. Samarasinghe9M. Waleed Gaber10Department of Pediatrics, University of Tennessee Health Science Center (UTHSC) and Children’s Foundation Research Institute, Le Bonheur Children’s Hospital, Memphis, TN, USADepartment of Pediatrics, University of Tennessee Health Science Center (UTHSC) and Children’s Foundation Research Institute, Le Bonheur Children’s Hospital, Memphis, TN, USADepartment of Pediatrics, University of Tennessee Health Science Center (UTHSC) and Children’s Foundation Research Institute, Le Bonheur Children’s Hospital, Memphis, TN, USADepartment of Pediatrics, University of Tennessee Health Science Center (UTHSC) and Children’s Foundation Research Institute, Le Bonheur Children’s Hospital, Memphis, TN, USADepartment of Pediatrics, University of Tennessee Health Science Center (UTHSC) and Children’s Foundation Research Institute, Le Bonheur Children’s Hospital, Memphis, TN, USADepartment of Pediatrics, University of Tennessee Health Science Center (UTHSC) and Children’s Foundation Research Institute, Le Bonheur Children’s Hospital, Memphis, TN, USADepartment of Pediatrics, University of Tennessee Health Science Center (UTHSC) and Children’s Foundation Research Institute, Le Bonheur Children’s Hospital, Memphis, TN, USADepartment of Pediatrics, University of Tennessee Health Science Center (UTHSC) and Children’s Foundation Research Institute, Le Bonheur Children’s Hospital, Memphis, TN, USADepartment of Pediatrics, University of Tennessee Health Science Center (UTHSC) and Children’s Foundation Research Institute, Le Bonheur Children’s Hospital, Memphis, TN, USADepartment of Pediatrics, University of Tennessee Health Science Center (UTHSC) and Children’s Foundation Research Institute, Le Bonheur Children’s Hospital, Memphis, TN, USADepartment of Pediatrics and Hematology-Oncology, Baylor College of Medicine and Texas Children’s Cancer Center, Houston, TX, USAOne of the unmet needs for asthma management is a new therapeutic agent with both anti-inflammatory and anti-smooth muscle (ASM) remodeling effects. The mannose receptor (MR) family plays an important role in allergen uptake and processing of major allergens Der p 1 and Fel d 1. We have previously reported that ASM cells express a mannose receptor (ASM-MR) and that mannan derived from Saccharomyces cerevisiae (SC-MN) inhibits mannosyl-rich lysosomal hydrolase-induced bovine ASM cell proliferation. Using a humanized transgenic mouse strain (huASM-MRC2) expressing the human MRC2 receptor in a SM tissue-specific manner, we have demonstrated that ASM hyperplasia/hypertrophy can occur as early as 15 days after allergen challenge in this mouse model and this phenomenon is preventable with SC-MN treatment. This proof-of-concept study would facilitate future development of a potential asthma therapeutic agent with dual function of anti-inflammatory and anti-smooth muscle remodeling effects.http://dx.doi.org/10.1155/2017/3432701
spellingShingle D. Betty Lew
Christie F. Michael
Tracie Overbeck
W. Scout Robinson
Erin L. Rohman
Jeffrey M. Lehman
Jennifer K. Patel
Brandi Eiseman
Kim S. LeMessurier
Amali E. Samarasinghe
M. Waleed Gaber
Beneficial Effects of Prebiotic Saccharomyces cerevisiae Mannan on Allergic Asthma Mouse Models
Journal of Immunology Research
title Beneficial Effects of Prebiotic Saccharomyces cerevisiae Mannan on Allergic Asthma Mouse Models
title_full Beneficial Effects of Prebiotic Saccharomyces cerevisiae Mannan on Allergic Asthma Mouse Models
title_fullStr Beneficial Effects of Prebiotic Saccharomyces cerevisiae Mannan on Allergic Asthma Mouse Models
title_full_unstemmed Beneficial Effects of Prebiotic Saccharomyces cerevisiae Mannan on Allergic Asthma Mouse Models
title_short Beneficial Effects of Prebiotic Saccharomyces cerevisiae Mannan on Allergic Asthma Mouse Models
title_sort beneficial effects of prebiotic saccharomyces cerevisiae mannan on allergic asthma mouse models
url http://dx.doi.org/10.1155/2017/3432701
work_keys_str_mv AT dbettylew beneficialeffectsofprebioticsaccharomycescerevisiaemannanonallergicasthmamousemodels
AT christiefmichael beneficialeffectsofprebioticsaccharomycescerevisiaemannanonallergicasthmamousemodels
AT tracieoverbeck beneficialeffectsofprebioticsaccharomycescerevisiaemannanonallergicasthmamousemodels
AT wscoutrobinson beneficialeffectsofprebioticsaccharomycescerevisiaemannanonallergicasthmamousemodels
AT erinlrohman beneficialeffectsofprebioticsaccharomycescerevisiaemannanonallergicasthmamousemodels
AT jeffreymlehman beneficialeffectsofprebioticsaccharomycescerevisiaemannanonallergicasthmamousemodels
AT jenniferkpatel beneficialeffectsofprebioticsaccharomycescerevisiaemannanonallergicasthmamousemodels
AT brandieiseman beneficialeffectsofprebioticsaccharomycescerevisiaemannanonallergicasthmamousemodels
AT kimslemessurier beneficialeffectsofprebioticsaccharomycescerevisiaemannanonallergicasthmamousemodels
AT amaliesamarasinghe beneficialeffectsofprebioticsaccharomycescerevisiaemannanonallergicasthmamousemodels
AT mwaleedgaber beneficialeffectsofprebioticsaccharomycescerevisiaemannanonallergicasthmamousemodels